Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization

NCT02479620 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Limb Ischemia

Interventions

DRUG: Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL

Sponsor

Mercator MedSystems, Inc.